Richard L. Wasserman MD PhD

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Medical Director of Pediatric Allergy and Immunology, Medical City Children's Hospital

7153 Lavendale AveDallas, TX 75230
Phone+1 214-697-7211

Dr. Wasserman is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wasserman's full profile Already have an account?

Summary

Dr. Richard Wasserman is an allergist and immunologist based in Dallas, TX, specializing in immunodeficiency, food allergy, and other allergic conditions in adults and children. He completed his medical education and training at prominent institutions such as Rockefeller University Hospital and the Children's Hospital of Philadelphia. Dr. Wasserman serves as Medical Director at Medical City Dallas and has held numerous academic and leadership roles, including positions at Baylor University Medical Center and Children's Medical Center Dallas. His research includes studies of immunoglobulin therapy, food allergy, and asthma, with a range of publications and participation in more than 125 clinical trials. A co-founder of the Consortium of Independent Immunology Clinics and the non-profit Food Allergy Support Team, he has published more than 170 peer-reviewed articles and book chapters. He has been honored as the Allergy/Immunology Teacher of the Year from the University of Texas Southwestern Medical School.

Education & Training

Rockefeller University HospitalPost-Doctoral Fellowship, 1980 - 1982
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1977 - 1980
University of Texas Southwestern Medical SchoolClass of 1977
University of Texas Southwestern Medical CenterFellowship, Cancer Immunology, 1976
City University of New York, Sciences Mt. Sinai School of MedicinePh.D., Biomedical Sciences, 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 1983 - 2026
PA State Medical License 1978 - 1984
NJ State Medical License Active through 1982
NY State Medical License 1980 - 1982
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Achievements and Innovations Award for Best Workflows “in recognition of important accomplishments, innovations and solutions that advance effective electronic medical records.” Centricity Healthcare User Group, 2005
Allergy/Immunology Teacher of the Year University of Texas Southwestern Medical School, 1995-1996
Volunteer of the Year 1995-1996 American Lung Association-North Texas Affiliate, 1995-1996

Clinical Trials

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy
COMPLETED
PHASE3
A Clinical Study of Intravenous Immunoglobulin
COMPLETED
PHASE3

Publications & Presentations

PubMed

Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).
Chaim M Roifman, Donald McNeil, William Lumry, Richard L Wasserman, Henry Kanarek
Advances in Therapy. 2026-07-01
2 citations
Patient-Reported Outcomes on Food Immunotherapy Differ Between Countries and Foods: Results From COFAITH.
Pablo Rodríguez Del Río, Carmen Riggioni, Antoine Deschildre, Matthew Greenhawt, Sabine Schnadt
The Journal of Allergy and Clinical Immunology. in Practice. 2025-08-01
1 citations
10 ways to improve your management of food allergy.
Aikaterini Anagnostou, Jay Lieberman, Theresa Bingemann, Tim Buckey, Antonella Cianferoni
Annals of Allergy, Asthma & Immunology. 2025-05-01

Journal Articles

Intravenous Gammaglobulin Prophylaxis for Newborn Infants.
Wasserman RL, Pediatr. Inf. Dis. 5:620-621
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy.
Orange JS, Belohradsky BH, Berger M, Borte M, Hagan J, Jolles S, Wasserman RL, Baggish JS, Saunders R, Grimbacher B, Clin Exp Immunology. 2012: 169:172-181
Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke OH, Wasserman RL, Asthma and Allergy Proc. 33:354-61

Books/Book Chapters

Pharmacokinetics of a new 10% Intravenous Immunoglobulin.
Chapter: Pharmacokinetics of a new 10% Intravenous Immunoglobulin
Page 272 - 278Wasserman RL, Church JA, Peter HH, et.alEur J Pharm Sci 37, 28
Structure and evolution of immunoglobulin heavy chain variable regions.
Page 3 - 18Capra JD, Wasserman RL, Querinjean P, Kehoe JMFEBS Proceedings, Budapest
The Glycoconjugates.
Chapter: Immunoglobulins
Wasserman RL, Capra JDEditors: MI Horowitz, W Pigman.Academic Press, New York

Abstracts/Posters

Subcutaneous Immunoglobulin Replacement Therapy for Primary Immunodeficiency: High-Dose versus Low-Dose Treatment using Hizentra.
Hagan J, Wasserman RL, Zenker O, Borte M, AAAAI 2011 International Conference
Rapid Clearance of L-Proline After Intravenous and Subcutaneous Infusion With L-Proline–Stabilized Immunoglobulin Replacement Products.
Hagan JB, Robak T, Church JA, Rojavin M, Wasserman RL, Clinical Immunology Society Annual Meeting 2011
Clinical Immunology Society Tolerability of Human Immunoglobulin 10% (IgG) Administered Subcutaneously (SC) or Facilitated With Recombinant Human Hyaluronidase (rHuPH2...
Melamed I, Wasserman RL, Stein M, Rubinstein A, McCoy B, Engl W, Leibl H, Gelmont D, Schiff RI and the rHuPH20-facilitated IGSC Study Group, Clinical Immunology Society Annual Meeting 2011

Other

Common Infusion-Related Reactions to Subcutaneous Immunoglobulin Therapy: Managing Patient Expectations.
Wasserman RL, Patient Preference and Adherence. 2008:2
http://www.dovepress.com//common-infusion-related-reactions-to-subcutaneous-immunoglobulin-thera-pee

Press Mentions

Is It Spring Allergies or COVID-19? Here's What to KnowApril 7th, 2022
Pollen Count Chicago: What's Highest Right Now and When You Might See ReliefSeptember 9th, 2021
Should You Add Bee Pollen to Your Smoothies? Here’s What You Need to Know FirstOctober 18th, 2019